The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac Surgery
Status:
Unknown status
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
The investigators aim to evaluate the roles of α7nAchR in the mechanisms of dexmedetomidine
in improving delirium after cardiac surgery. The results of this study would lay the
foundation for revealing the mechanisms of dexmedetomidine improving delirium after cardiac
surgery and provide a new idea to the early treatment of delirium.
Phase:
N/A
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University